Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - Loss AllowanceNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RedHill Biopharma (RDHL) Goodwill & Intangibles: 2011-2024

Historic Goodwill & Intangibles for RedHill Biopharma (RDHL) over the last 14 years, with Dec 2024 value amounting to $5.5 million.

  • RedHill Biopharma's Goodwill & Intangibles rose 249.48% to $28.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $28.3 million, marking a year-over-year increase of 249.48%. This contributed to the annual value of $5.5 million for FY2024, which is 0.56% down from last year.
  • RedHill Biopharma's Goodwill & Intangibles amounted to $5.5 million in FY2024, which was down 0.56% from $5.6 million recorded in FY2023.
  • RedHill Biopharma's Goodwill & Intangibles' 5-year high stood at $89.4 million during FY2020, with a 5-year trough of $5.5 million in FY2024.
  • For the 3-year period, RedHill Biopharma's Goodwill & Intangibles averaged around $33.5 million, with its median value being $5.6 million (2023).
  • In the last 5 years, RedHill Biopharma's Goodwill & Intangibles surged by 658.17% in 2020 and then plummeted by 93.76% in 2023.
  • Yearly analysis of 5 years shows RedHill Biopharma's Goodwill & Intangibles stood at $89.4 million in 2020, then remained steady at $89.4 million in 2021, then remained steady at $89.4 million in 2022, then crashed by 93.76% to $5.6 million in 2023, then dropped by 0.56% to $5.5 million in 2024.